Possible dual role of anti-idiotypic antibodies in combined passive and active immunotherapy in honeybee sting allergy. (Q52536215)

2 May 2018

title

Possible dual role of anti-idiotypic antibodies in combined passive and active immunotherapy in honeybee sting allergy. (English)

1 reference

2 May 2018

1 reference

1 reference

Boutin Y

1

1 reference

2 May 2018

Jobin M

2

1 reference

2 May 2018

Bédard PM

3

1 reference

2 May 2018

Hébert M

4

1 reference

2 May 2018

Hébert J

5

1 reference

2 May 2018

language of work or name

English

0 references

publication date

1 June 1994

1 reference

2 May 2018

The Journal of Allergy and Clinical Immunology

published in

1 reference

2 May 2018

volume

93

1 reference

2 May 2018

issue

6

1 reference

2 May 2018

page(s)

1039-1046

1 reference

2 May 2018

Stinging insect allergy: natural history and modification with venom immunotherapy.

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0091-6749%2894%2970053-2

7 January 2021

Studies of 400 Hymenoptera sting deaths in the United States

1 reference

https://api.crossref.org/works/10.1016%2FS0091-6749%2894%2970053-2

7 January 2021

Insect allergy: The state of the art

1 reference

https://api.crossref.org/works/10.1016%2FS0091-6749%2894%2970053-2

7 January 2021

Rush venom immunotherapy program for honeybee sting sensitivity

1 reference

https://api.crossref.org/works/10.1016%2FS0091-6749%2894%2970053-2

7 January 2021

Combination of passive and active immunization in honeybee venom immunotherapy.

1 reference

https://api.crossref.org/works/10.1016%2FS0091-6749%2894%2970053-2

7 January 2021

Immunotherapy with honeybee venom and yellow jacket venom is different regarding efficacy and safety

1 reference

https://api.crossref.org/works/10.1016%2FS0091-6749%2894%2970053-2

7 January 2021

Combined active and passive immunotherapy in honeybee-sting allergy.

1 reference

https://api.crossref.org/works/10.1016%2FS0091-6749%2894%2970053-2

7 January 2021

Isotypic and antigenic restriction of the blocking antibody response to ryegrass pollen: correlation of rye group I antigen-specific IgG1 with clinical response

1 reference

https://api.crossref.org/works/10.1016%2FS0091-6749%2894%2970053-2

7 January 2021

Immunotherapy with Hymenoptera venoms. Position paper of the Working Group on Immunotherapy of the European Academy of Allergy and Clinical Immunology

1 reference

https://api.crossref.org/works/10.1016%2FS0091-6749%2894%2970053-2

7 January 2021

Detection of auto-anti-idiotypic antibodies to Lol p I (rye I) IgE antibodies in human sera by the use of murine idiotypes: levels in atopic and non-atopic subjects and effects of immunotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS0091-6749%2894%2970053-2

7 January 2021

Regulation of immunoglobulin E antibody synthesis in man by antiidiotypic antibodies

1 reference

https://api.crossref.org/works/10.1016%2FS0091-6749%2894%2970053-2

7 January 2021

Bee venom anti-idiotypic antibody is associated with protection in beekeepers and bee sting-sensitive patients receiving immunotherapy against allergic reactions

1 reference

https://api.crossref.org/works/10.1016%2FS0091-6749%2894%2970053-2

7 January 2021

Allergic rhinitis to ragweed pollen. II. Modulation of histamine-releasing factor production by specific immunotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS0091-6749%2894%2970053-2

7 January 2021

Increased compound 48/80 induced local histamine release from nonlesional skin of patients with chronic urticaria

1 reference

https://api.crossref.org/works/10.1016%2FS0091-6749%2894%2970053-2

7 January 2021

An open-label study of high-dose intravenous immunoglobulin in severe childhood asthma

1 reference

https://api.crossref.org/works/10.1016%2FS0091-6749%2894%2970053-2

7 January 2021

Manipulating the Immune System with Immune Globulin

1 reference

https://api.crossref.org/works/10.1016%2FS0091-6749%2894%2970053-2

7 January 2021

Antiidiotypic immunosuppression and its treatment with human immunoglobulin preparations

1 reference

https://api.crossref.org/works/10.1016%2FS0091-6749%2894%2970053-2

7 January 2021

The concept of anti-idiotypic regulation of selected autoimmune diseases by intravenous immunoglobulin

1 reference

https://api.crossref.org/works/10.1016%2FS0091-6749%2894%2970053-2

7 January 2021

Detection of human auto-anti-idiotypic antibodies (Ab2). I. Isolation and characterization of Ab2 in the serum of a ragweed immunotherapy-treated patient

1 reference

https://api.crossref.org/works/10.1016%2FS0091-6749%2894%2970053-2

7 January 2021

Identification of anti-idiotypic antibodies in the sera of ryegrass-allergic and nonallergic individuals

1 reference

https://api.crossref.org/works/10.1016%2FS0091-6749%2894%2970053-2

7 January 2021

Human immune response to allergens of house dust mite, Dermatophagoides pteronyssinus. IV. Occurrence of natural autologous anti-idiotypic antibodies

1 reference

https://api.crossref.org/works/10.1016%2FS0091-6749%2894%2970053-2

7 January 2021

10.1016/S0091-6749(94)70053-2

Identifiers

DOI

1 reference

2 May 2018

1 reference

2 May 2018